Endocrinology & metabolism
Hormones & metabolism clinical trials
Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We’re tracking 7,628 recruiting studies in this area right now.
By phase
- Not applicable5,351
- Phase 2606
- Phase 1560
- Phase 3419
- Phase 4318
- Phase 1/Phase 2288
- Phase 2/Phase 386
Top conditions
- Obesity618
- Ovarian Cancer336
- Pancreatic Cancer288
- Type 2 Diabetes277
- Diabetes192
- Diabetes Mellitus184
- Diabetes Mellitus, Type 2172
- Hypertension138
- Type 1 Diabetes132
- Metabolic Syndrome127
- Obesity & Overweight125
- Breast Cancer111
- Overweight106
- Cardiovascular Diseases105
- Amyotrophic Lateral Sclerosis102
- Pancreas Cancer91
- Colorectal Cancer90
- Endometrial Cancer86
Leading sponsors
- Mayo Clinic87
- Novo Nordisk A/S64
- University of Colorado, Denver53
- Assistance Publique - Hôpitaux de Paris52
- M.D. Anderson Cancer Center42
- Eli Lilly and Company41
- Massachusetts General Hospital41
- IRCCS Azienda Ospedaliero-Universitaria di Bologna40
- National Taiwan University Hospital40
- Cairo University38
Where studies are running
- California521
- Maryland179
- Alabama176
- Arizona170
- Florida165
- Texas159
- Massachusetts151
- New York142
- Colorado115
- Pennsylvania114
Recruiting studies7,628 total
- NCT06851663RecruitingPhase 2/Phase 3
New PET scan for many solid tumors
This trial tests a new type of PET scan that uses a special antibody to find a marker called Trop2 on many common solid tumors. It may help doctors see tumors more clearly without needing a biopsy.
ShanghaiAges 18–75 - NCT04252066Recruiting
Pregnancy and breastfeeding study for women with Fabry disease
This study follows pregnant and breastfeeding women with Fabry disease (and their infants) to better understand what happens during pregnancy and early life. You may or may not be taking migalastat, and the goal is to gather real-world information that could help future care.
Philadelphia, PennsylvaniaAges Any age - NCT05203640Recruiting
Strength exercise study for post-menopausal type 1 diabetes
This study checks whether a resistance (strength) exercise program changes blood sugar levels in post-menopausal women with type 1 diabetes. You may be asked to do supervised lab-based exercise sessions near the University of Alberta.
Edmonton, AlbertaAges 45–75 - NCT06203860Recruiting
Heart-focused clinic for diabetes and heart disease
This study is testing whether a special heart-focused clinic can help people with type 2 diabetes who also have heart or blood vessel problems. If you have both diabetes and a heart condition like prior heart attack, stroke, heart failure, or hard-to-control high blood pressure, this program may support your health.
Svendborg, Region SyddanmarkAges 19 years+ - NCT06149546Recruiting
Nutrition therapy for people having chemotherapy for pancreatic cancer
This trial tests whether a special nutrition program can help people with pancreatic cancer who are getting chemotherapy before surgery. The program includes diet changes, supplements, and exercise support to see if it improves strength, weight, and overall well-being.
Dublin, LeinsterAges 18 years+ - NCT06618027Recruiting
Mindfulness program for teens with type 1 diabetes and mood concerns
This trial tests a mindfulness program designed to help teens with type 1 diabetes who are also dealing with feelings of depression or anxiety. The goal is to see if this program can improve their mood and overall well-being.
Aurora, ColoradoAges 13–17 - NCT06729242Recruiting
How menstrual cycle phases affect exercise and blood sugar in type 1 diabetes
This study looks at how the menstrual cycle changes the way your body responds to aerobic exercise or high-intensity interval training (HIIT) when you have type 1 diabetes. It may help you understand the best time to exercise for better blood sugar control.
Valencia, Select OneAges 18–45 - NCT06845046Recruiting
Improving muscle health for veterans with HIV
This study tests a way to help veterans with HIV build stronger muscles. It may help improve your strength and overall health.
Nashville, TennesseeAges 20–80 - NCT06836609RecruitingPhase 1/Phase 2
Study of a new drug for fatty liver disease (MASLD/MASH)
This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.
Chandler, ArizonaAges 18–65 - NCT06839235RecruitingPhase 1/Phase 2
Testing ABO-101 for primary hyperoxaluria type 1
This trial tests a new treatment called ABO-101 for people with primary hyperoxaluria type 1, a rare disease that causes high oxalate levels in urine. The study aims to see if ABO-101 can lower oxalate and protect kidney function.
Rochester, MinnesotaAges 6–64 - NCT06840002RecruitingPhase 1/Phase 2
Targeted drug plus chemotherapy for recurrent ovarian cancer
This trial tests a new targeted drug, SHR-A1811, combined with chemotherapy for women whose ovarian cancer has returned but still responds to platinum-based drugs. The goal is to see if the combination works better than chemotherapy alone.
Wuhan, HubeiAges 18–75 - NCT06840886RecruitingPhase 1
Study of PHST001 for advanced solid tumors
This trial tests an experimental drug called PHST001 for people with advanced solid tumors that have stopped responding to standard treatments. The study aims to see if PHST001 can help shrink or control the tumor.
Beverly Hills, CaliforniaAges 18 years+ - NCT06842186RecruitingPhase 1/Phase 2
Study of WVE-007 for overweight or obesity
This trial tests an experimental drug called WVE-007 for people who are overweight or have obesity. It aims to help with weight loss and is looking at both a group without diabetes and a group with prediabetes or type 2 diabetes.
Baltimore, MarylandAges 18–60 - NCT06838143Recruiting
Ilaris real-world study for periodic fevers and sJIA
This study watches how people with certain periodic fever syndromes or a severe type of childhood arthritis (sJIA) do on the medicine Ilaris during their regular doctor visits. It collects information to see how well the medicine works in everyday care.
SeoulAges 2–100 - NCT06838286Recruiting
Study of triple therapy for type 2 diabetes
This study looks at the safety and effectiveness of adding a third oral diabetes medicine to your current two-drug combination. It is for adults with type 2 diabetes whose blood sugar is not well controlled on metformin plus one other pill.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT06839144RecruitingPhase 2
Medications before surgery to slow ovarian cancer growth
This trial tests whether giving two common medications before and after surgery can slow the growth of ovarian cancer. The medications may help reduce stress signals that could make cancer spread faster during surgery.
Ramat GanAges 20–85 - NCT06307080Recruiting
Combined ablation and immunotherapy for pancreatic cancer with liver spread
This study tests a new treatment combining tumor destruction with heat/cold (ablation) and an immunotherapy drug (PD-1) for people whose pancreatic cancer has spread to the liver. The goal is to help the immune system fight the cancer better.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06843499Recruiting
AI eye screening for AMD and diabetic retinopathy
This trial tests an AI program called VeriSee that helps doctors check for eye problems like age-related macular degeneration (AMD) and diabetic retinopathy (DR). It compares the AI's accuracy and costs to standard care in regular eye clinics.
Taipei, TaiwanAges 20 years+ - NCT06843811Enrolling by invitationPhase 2
Sirolimus for Leigh Syndrome
This trial tests if sirolimus can help people with Leigh syndrome. It aims to see if the drug can improve neurological symptoms and is looking for participants aged 6 months to 55 years.
Philadelphia, PennsylvaniaAges 6 months–55 years - NCT06837805Enrolling by invitation
Produce prescription program for people with diabetes or prediabetes
This study provides free fruits and vegetables to adults with prediabetes or diabetes who are on Medicaid or eligible for SNAP. It aims to see if easier access to healthy food can improve your health.
Ames, IowaAges 18 years+ - NCT06843330Recruiting
Lactate meter accuracy for children with GSD type Ia
This trial tests whether a simple finger-stick lactate meter gives accurate results for children and adults with a specific type of glycogen storage disease (GSD Ia). It aims to find a faster, easier way to monitor health during emergency visits or hospital stays.
Hartford, ConnecticutAges birth–60 years - NCT06842732Recruiting
Text messages to prevent wasting in HIV-affected children in Kenya
This trial tests if two-way text messages (SMS) can help caregivers recognize early signs of malnutrition (wasting) in children who have HIV or were exposed to HIV but are uninfected. The goal is to prevent wasting and keep children healthy.
Homa BayAges 6 months–2 years - NCT06843629Recruiting
PET scan test for MSLN in cancer patients
This study uses a special PET scan to look for a protein called MSLN in certain cancers like pancreatic, ovarian, and lung cancer. It aims to see if this imaging method can help doctors understand your tumor better.
Wuhan, HubeiAges 18–65 - NCT06841341Enrolling by invitation
Predicting breathing problems in ALS
This study uses ultrasound and electrical tests of breathing muscles and nerves to see if they can predict breathing failure in people with ALS. This could help doctors know when a patient might need breathing support.
Krakow, Lesser Poland VoivodeshipAges 18–80
Common questions
- How many hormones & metabolism clinical trials are recruiting?
- Clin2 is tracking 7,628 recruiting endocrinology & metabolism studies from the U.S. registry right now, out of 12,015 we cover in this area in total.
- What does “Hormones & metabolism” cover here?
- Diabetes, obesity, thyroid, and other conditions of the body’s hormones and metabolism. We group each study into hormones & metabolism based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a hormones & metabolism trial near me?
- Use the search to filter hormones & metabolism studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.